Thyroid disorders

Clinics in Family Practice

Volumn 4, Issue 3, 2002, Pages 667-701

  Wilson, George R ^a  

^a UNIVERSITY OF FLORIDA COLLEGE OF MEDICINE   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

AMIODARONE; ANTITHYROID AGENT; BETA ADRENERGIC RECEPTOR BLOCKING AGENT; CALCIUM CHANNEL BLOCKING AGENT; CARBIMAZOLE; CYCLOSPORIN A; DOPAMINE; FUROSEMIDE; GLUCOCORTICOID; LEVOTHYROXINE; LIOTHYRONINE; LITHIUM SALT; LONG ACTING THYROID STIMULATOR; NONSTEROID ANTIINFLAMMATORY AGENT; OCTREOTIDE; PARACETAMOL; PROPYLTHIOURACIL; RECOMBINANT CYTOKINE; SALICYLIC ACID DERIVATIVE; STEROID; TAMOXIFEN; THIAMAZOLE; THYROGLOBULIN ANTIBODY; THYROID HORMONE; THYROID PEROXIDASE; THYROTROPIN; THYROTROPIN RECEPTOR; THYROTROPIN RECEPTOR ANTIBODY; THYROXINE; UNINDEXED DRUG;

AGRANULOCYTOSIS; ASPIRATION BIOPSY; CLINICAL FEATURE; DEPRESSION; DRUG EFFICACY; DRUG SAFETY; ECHOGRAPHY; EUTHYROID SICK SYNDROME; FEMALE; FEVER; GOITER; GRAVES DISEASE; HASHIMOTO DISEASE; HUMAN; HYPOTHALAMUS HYPOPHYSIS THYROID SYSTEM; HYPOTHYROIDISM; LABORATORY DIAGNOSIS; NUCLEAR MAGNETIC RESONANCE IMAGING; PATHOPHYSIOLOGY; PRURITUS; PUERPERIUM; RASH; REVIEW; THYROID CANCER; THYROID CYST; THYROID DISEASE; THYROID FUNCTION; THYROID HORMONE SYNTHESIS; THYROID NODULE; THYROID SCINTISCANNING; THYROID TUMOR; THYROIDECTOMY; THYROIDITIS; THYROTOXICOSIS; THYROTROPIN BLOOD LEVEL;

EID: 0036763692     PISSN: 15225720     EISSN: None     Source Type: Journal    
DOI: 10.1016/S1522-5720(02)00037-5     Document Type: Review

References (120)

1. Dayan CM, Daniels GH. Chronic autoimmune thyroiditis [review]. N Engl J Med 1996;335(2):99-107.
2. Vanderpump MPJ, Tunbridge WMG, French JM, et al. The incidence of thyroid disorders in the community: a twenty-year follow-up of the Whickham Survey. Clin Endocrinol 1995;43:55.
3. Brander A, Viikinkoski P, Nickels J, et al. Thyroid gland: US screening in middle-aged women with no previous thyroid disease. Radiology 1989;173:507.
4. Jarlov AE, Nygaard B, Hegedhs L, et al. Observer variations in the clinical and laboratory evaluation of patients with thyroid dysfunction and goiter. Thyroid 1998;8:393.
5. Danese MD, Powe NR, Sawin CT, et al. Screening for mild thyroid failure at the periodic health examination: a decision and cost-effectiveness analysis. JAMA 1996;276:285.
6. Stanbury JB, Ermans AM, Hetzel BS, et al. Endemic goitre and cretinism: public health significance and prevention. WHO Chron 1974;28:220.
7. Cooper DS. Clinical practice. Subclinical hypothyroidism [review]. N Engl J Med 2001;345(4):260-5.
8. Sawin CT, Castelli WP, Hershman JM, et al. The aging thyroid. Thyroid deficiency in the Framingham Study. Arch Intern Med 1985;145:1386.
9. Dunn JT, Dunn AD. Thyroglobulin: chemistry, biosynthesis, and proteolysis. In: Braverman LE, Utiger RD, editors. The thyroid. 8th edition. Philadelphia: Lippencott, Williams and Wilkins; 2000. p. 91-104.
10. Shankar P, Kilvert A, Fox C. Changing thyroid status related to pregnancy. Postgrad Med J 2001;77(911):591-2.
11. Chopra IJ, Solomon DH, Chua Teco GN. Thyroxine: just a prohormone or a hormone too? J Clin Endocrinol Metab 1973;36:1959.
12. Oppenheimer JH, Schwartz HL, Mariash CN, et al. Advances in our understanding of thyroid hormone action at the cellular level. Endocr Rev 1987;8:288.
13. Yamada M, Monden T, Satoh T, et al. Differential regulation of thyrotropin-releasing hormone receptor mRNA levels by thyroid hormone in vivo and in vitro (GH3 cells). Biochem Biophys Res Commun 1992;184:367.
14. Chopra IJ. A radioimmunoassay for measurement of 3,3′,5′-tri-iodothyronine (reverse T3). J Clin Invest 1974;54:583.
15. Bartalena L, Robbins J. Variations in thyroid hormone transport proteins and their clinical implications. Thyroid 1992;2:237.
16. Mendel CM. The free hormone hypothesis: a physiologically based mathematical model. Endocr Rev 1989;10:232.
17. Hamada N, Ohno M, Morii H, et al. Is it necessary to adjust the replacement dose of thyroid hormone to the season in patients with hypothyroidism? Metabolism 1984;33:215.
18. Toft AD. Clinical practice. Subclinical hyperthyroidism. N Engl J Med 2001;345(7):512-6.
19. Trivalle C, Doucet J, Chassagne P, et al. Differences in the signs and symptoms of hyperthyroidism in older and younger patients. J Am Geriatr Soc 1996;44:50.
20. Ramsay I. Thyrotoxic muscle disease. Postgrad Med J 1968;44:385.
21. Nordyke RA, Gilbert Jr FI, Harada ASM. Graves' disease: influence of age on clinical findings. Arch Intern Med 1988;148:626.
22. Trzepacz PT, Klein I, Robert M, et al. Graves' disease: an analysis of thyroid hormone levels and hyperthyroid signs and symptoms. Am J Med 1989;187:558.
23. Tietgens ST, Leinung MC. Thyroid storm. Med Clin N Am 1995;79:169.
24. Wagle AC, Wagle SA, Patel AG. Apathetic form of thyrotoxicosis. Can J Psychiatry 1998;43:747.
25. Fatourechi V. Adverse effects of subclinical hyperthyroidism. Lancet 2001;358(9285):856-7.
26. Faber J, Galloe AM. Changes in bone mass during prolonged subclinical hyperthyroidism due to L-thyroxine treatment: a meta-analysis. Eur J Endocrinol 1994;130:631.
27. Gammage M, Franklyn J. Hypothyroidism, thyroxine treatment and the heart. Heart 1997;77:189.
28. Helfand M, Redfern C. Clinical guideline, Part 2. Screening for thyroid disease: an update. Ann Intern Med 1998;129:144.
29. Bonar BD, McColgan B, Smith DF, et al. Hypothyroidism and aging: the Rosses' survey. Thyroid 2000;10(9):821-7.
30. Heymann WR. The skip and connective tissue in hypothyroidism. In: Braverman LE, Utiger RD, editors. The thyroid, 8th edition. Philadelphia, Lippencott, Williams and Wilkins; 2000. p. 774-6.
31. Das KC, Mukherjee M, Sarkar TK, et al. Erythropoiesis and erythropoietin in hypo- and hyperthyroidism. J Clin Endocrinol Metab 1975;40:211.
32. Dalton RG, Dewar MS, Savidge GF, et al. Hypothyroidism as a cause of acquired von Willebrand's disease. Lancet 1987;1:1007.
33. Ford HC, Carter JM. Hemostasis in hypothyroidism. Postgrad Med J 1990;66:280.
34. Bruggers CS, McElligott K, Rallison ML. Acquired von Willebrand disease in twins with autoimmune hypothyroidism: response to desmopressin and L-thyroxine therapy. J Pediatr 1994;125(6 Pt 1):911-3.
35. Notsu K, Ito Y, Furuya H, et al. Incidence of hyperprolactinemia in patients with Hashimoto's thyroiditis. Endocr J 1997;44(1):89-94.
36. Grubb MR, Chakeres D, Malarkey WB. Patients with primary hypothyroidism presenting as prolactinomas. Am J Med 1987;83:765.
37. Rajagopal KR, Albrecht PH, Derderian SS, et al. Obstructive sleep apnea in hypothyroidism. Ann Intern Med 1984;101:491.
38. Cooper DS, Halpern R, Wood LC, et al. L-thyroxine therapy in subclinical hypothyroidism: a double blind placebo-controlled trial. Ann Intern Med 1984;101:18.
39. Buvevicius R, Kazanavicius G, Zalinkevicius R, et al. Effects of thyroxine as compared with thyroxine plus triiodothyronine in patients with hypothyroidism. N Engl J Med 1999;340:424.
40. Toft AD. Thyroxine therapy. N Engl J Med 1994;331:174.
41. Karlsberg RA, Friscia DA, Aronow WS, et al. Deleterious influence of hypothyroidism on evolving myocardial infarction in conscious dogs. J Clin Invest 1981;67:1024.
42. Keating Jr FR, Parkin TW, Selby JB, et al. Treatment of heart disease associated with myxedema. Prog Cardiovasc Dis 1961;3:364.
43. Weetman AP. Determinants of autoimmune thyroid disease. Nat Immunol 2001;2(9):769-70.
44. Weetman AP. Chronic autoimmune thyroiditis. In: Braverman LE, Utiger RD, editors. The thyroid. 8th edition. Philadelphia: Lippincott, Williams and Wilkins; 2000. p. 722.
45. Rose NR, Burek CL. Autoantibodies to thyroglobulin in health and disease. Appl Biochem Biotechnol 2000;83(1-3):245-51; discussion 251-4, 297-313
46. Pop VJ, Maartens LH, Leusink G, et al. Are autoinumme thyroid dysfunction and depression related? J Clin Endocrinol Metab 1998;83:3194.
47. Mariotti S, Sansoni P, Barbesino G, et al. Thyroid and other organ-specific autoantibodies in healthy centenarians. Lancet 1992;339:1506.
48. Litta-Modignani R, Barantani E, Mazzolari M, et al. Chronic autoimmune thyroid disease. Ann Ital Med Int 1991;6(4):420-6.
49. LiVolsi VA. The pathology of autoimmune thyroid disease: a review. Thyroid 1994;4(3):333-9.
50. Spencer CA, Takeuchi M, Kazarosyan M, et al. Serum thyroglobulin autoantibodies: prevalence, influence of serum thyroglobulin measurement, and prognostic significance in patients with differentiated thyroid carcinoma. J Clin Endocrinol Metab 1998;83:1121.
51. Vitti P, Rago T, Chiovato L, et al. Clinical features of patients with Graves' disease undergoing remission after antithyroid drug treatment. Thyroid 1997;7:369.
52. Madec AM, Laurent MC, Lorej Y, et al. Thyroid stimulating antibodies: an aid to the strategy of treatment of Graves' disease? Clin Endocrinol 1984;21:247.
53. Giani C, Fierabracci P, Bonacci R, et al. Relationship between breast cancer and thyroid disease: relevance of autoimmune thyroid disorders in breast malignancy. J Clin Endocrinol Metab 1996;81:990.
54. deLuis DA, Varela C, de La Calle H, et al. Helicobacter pylori infection is markedly increased in patients with autoimmune atrophic thyroiditis. J Clin Gastroenterol 1998;26:249.
55. Kopp P. The TSH receptor and its role in thyroid disease. Cell Mol Life Sci 2001;58(9):1301-22.
56. Feldt-Rasmusen U, Schleusener H, Carayon P. Meta-analysis evaluation of the impact of thyrotropin receptor antibodies on long term remission after medical therapy of Graves' disease. J Clin Endocrinol Metab 1994;78:98.
57. Tonacchera M, Agretti P, De Marco G, et al. Thyroid resistance to TSH complicated by autoimmune thyroiditis. J Clin Endocrinol Metab 2001;86(9):4543-6.
58. Tomer Y, Davies TF. Infection, thyroid disease and autoinummity. Endocr Rev 1993;14:107.
59. Winsa B, Adami H-O, Bergstrom R, et al. Stressful life events and Graves' disease. Lancet 1991;338:1475.
60. Chiovato L, Barbesino G, Pinchera A. Graves' disease. In: DeGroot LJ, Jameson JL, editors. In: Endocrinology. Volume 2, 4th edition. Philadelphia: WB Saunders; 2001. p. 1430.
61. Vanderpump MPJ, Tunbridge WMG. The epidemiology of thyroid disease. In: Braverman LE, Utiger RD, editors. The thyroid. 8th edition. Philadelphia: Lippincott, Williams and Wilkins; 2000. p. 467-73.
62. Perros P, Crombie AL, Matthews JN, et al. Age and gender influence the severity of thyroid-associated ophthalmopathy: study of 101 patients attending a combined thyroid-eye clinic. Clin Endocrinol (Oxf) 1993;38(4):367-72.
63. Bartley GB. The differential diagnosis and classification of eyelid retraction. Ophthalmology 1996;103:168.
64. Perros P, Kendall-Taylor P, Crombie AL. Natural history of thyroid associated ophthalmopathy. Clin Endocrinol 1995;142:45.
65. Chang TC, Kao SCS, Huang KM. Octreotide and Graves' ophthalmopathy and pretibial myxedema. BMJ 1992;304:158.
66. Tallstedt L, Lundell G, Torring O, et al. Occurrence of ophthalmopathy after treatment for Graves' hyperthyroidism. N Engl J Med 1992;326:1733.
67. Hedley AJ, Young RE, Jones SJ, et al. Antithyroid drugs in the treatment of hyperthyroidism of Graves' disease: long-term follow-up of 434 patients. Clin Endocrinol 1989;31:209.
68. Benker G, Rienwein D, Kahaly G, et al. Is there a methimazole dose effect on remission rate in Grave's disease? Results from a long-term prospective study. Clin Endocrinol 1998;49:451.
69. Michelangeli V, Poon C, Taft J, et al. The prognostic value of thyrotropin receptor antibody measurement in the early stages of treatment of Graves' disease with antithyroid drugs. Thyroid 1998;8:119.
70. Shigemasa C, Kouchi T, Taniguchi S, et al. Autoimmune thyroiditis with transient thyrotoxicosis: comparison between painful thyroiditis and painless thyroiditis. Horm Res 1991;36(1-2):9-15.
71. Singer PA. Thyroiditis: acute, subacute, and chronic [review]. Med Clin N Am 1991;75(1):61-77.
72. Schubert MF, Kountz DS. Thyroiditis. A disease with many faces [review]. Postgrad Med J 1995;98(2):101-12.
73. Farid NR. Thyroiditis. Curr Ther Endocrinol Metab 1994;5:104-7.
74. Slatosky J, Shipton B, Wahba H. Thyroiditis: differential diagnosis and management [review]. Am Fam Physician 2000;61(4):1047-54.
75. Marion M, Latrofa F, Barbesino G, et al. Pathogenetic and clinical aspects of autoimmune thyroiditis [review]. Exp Clin Endocrinol Diabetes 1999;107(Suppl 3):S79-83.
76. Rose NR, Saboori AM, Rasooly L, et al. The role of iodine in autoimmune thyroiditis. [review]. Crit Rev Immunol 1997;17(5-6):511-7.
77. Metcalfe RA, Ball G, Kudesia G, et al. Failure to find an association between hepatitis C virus and thyroid autoimmunity. Thyroid 1997;7(3):421-4.
78. Izquierdo R. Thyroid peroxidase antibodies and pregnancy. Endocr Pract 2000;(3):278-9.
79. Padberg S, Heller K, Usadel KH, et al. One-year prophylactic treatment of euthyroid Hashimoto's thyroiditis patients with levothyroxine: is there a benefit? Thyroid 2001;11(3):249-55.
80. Takasu N, Yamada T, Takasu M, et al. Disappearance of thyrotropin-blocking antibodies and spontaneous recovery from hypothyroidism in autoimmune thyroiditis. N Engl J Med 1992;326:513.
81. Muller AF, Drexhage HA, Berghout A. Postpartum thyroiditis and autoimmune thyroiditis in women of childbearing age: recent insights and consequences for antenatal and postnatal care. Endocr Rev 2001;22(5):605-30.
82. Matsuzuka F, Miyauchi A, Katayama S, et al. Clinical aspects of primary thyroid lymphoma: diagnosis and treatment based on our experience of 119 cases. Thyroid 1993;3:93.
83. Emerson CH, Farwell AP. Sporadic silent thyroiditis, postpartum thyroiditis, and subacute thyroiditis. In: Braverman LE, Utiger RD, editors. The thyroid. 8th edition. Philadelphia: Lippencott, Williams and Wilkins; 2000. p. 578.
84. Lazarus JH, Ammari F, Oretti R, et al. Clinical aspects of recurrent postpartum thyroiditis. Br J Gen Pract 1997;47:305.
85. Premawardhana LD, Parkes AB, Ammari F, et al. Postpartum thyroiditis and long-term thyroid status: prognostic influence of thyroid peroxidase antibodies and ultrasound echogenicity. J Clin Endocrinol Metab 2000;85(1):71-5.
86. Othman S, Phillips D, Parkes A, et al. A long-term follow-up of postpartum thyroiditis. Clin Endocrinol (Oxf) 1990;32:559.
87. Stuckey BG, Kent GN, Allen JR: The biochemical and clinical course of postpartum thyroid dysfunction: the treatment decision. Clin Endocrinol (Oxf) 2001;54(3):377-83.
88. Kent HN, Stuckey BG, Allen JR, et al. Postpartum thyroid dysfunction: clinical assessment and relationship to psychiatric affective morbidity. Clin Endocrinol (Oxf) 1999;51(4):429-38.
89. Intenzo CM, Park CH, Kim SM, et al. Clinical, laboratory, and scintigraphic manifestations of subacute and chronic thyroiditis. Clin Nucl Med 1993;(4):302-6
90. Iitaka M, Momotani N, Ishii J, et al. Incidence of subacute thyroiditis recurrences after a prolonged latency: 24-year survey. J Clin Endocrinol Metab 1996;(2):466.
91. LiVolsi VA. Pathology of thyroid diseases. In: Braverman LE, Utiger RD, editors. The thyroid. 8th edition. Philadelphia: Lippincott, Williams and Wilkins; 2000. p. 488-511.
92. Studer H, Peter HJ, Gerber H. Natural heterogeneity of thyroid cells: the basis for understanding thyroid function and nodular goiter growth. Endoer Rev 1989;10( ):125-35.
93. Dumont JE, Maenhaut C, Pirson I, et al. Growth factors controlling the thyroid gland. Baillieres Clin Endocrinol Metab 1991;5:727.
94. Giuffrida D, Gharib H. Controversies in the management of cold, hot, and occult thyroid nodules. Am J Med 1995;99:642.
95. Landis SH, Murray T, Bolden S, et al. Cancer statistics, 1999. CA Cancer J Clin 1999;49:8.
96. Tan GH, Gharib H. Thyroid incidentalomas: management approaches to nonpalpable nodules discovered incidentally on thyroid imaging. Ann Intern Med 1997;126:226.
97. Jones MK: Management of nodular thyroid disease. The challenge remains identifying which palpable nodules are malignant. BMJ 2001;323(7308):293-4.
98. Hung W, Anderson KD, Chandra RS, et al. Solitary thyroid nodules in 71 children and adolescents. J Pediatr Surg 1992;27:1407.
99. Aeschmann S, Kopp PA, Kemura ET, et al. Morphological and functional polymorphism within clonal thyroid nodules. J Clin Invest 1993;77:846.
100. Bennedbaek FN, Hegedhs L. Management of the solitary thyroid nodule: results of a North American survey. J Clin Endocrinol Metab 2000;85(7):2493-8.
101. Ross DS. Hyperthyroidism, thyroid hormone therapy, and bone. Thyroid 1994;4:319.
102. Grant CS, Hay ID, Gough IR, et al. Local recurrence in papillary thyroid carcinoma: is extent of surgical resection important? Surgery 1988;104:954.
103. Amedee RG, Dhurandhar NR. Fine-needle aspiration biopsy [review]. Laryngoscope 2001;111(9):1551-7.
104. Arda IS, Yildirim S, Demirhan B, et al. Fine needle aspiration biopsy of thyroid nodules. Arch Dis Child 2001;85(4):313-7.
105. Asp AA, Georgitis W, Waldton EJ, et al. Fine needle aspiration of the thyroid. Am J Med 1987;83:489.
106. Mazzaferri EL. Thyroid carcinoma: papillary and follicular. In: Mazzaferri EL, Samaan N,\ editors. Endocrine tumors. Cambridge, England: Blackwell; 1993. p.278.
107. Chopra IJ. Euthyroid sick syndrome: is it a misnomer? J Clin Endocrinol Metab 1997;82:329.
108. Arem R, Thornby JI, Deppe SA. Comparison of thyroid hormone and cortisol measurements with APACHE II and TISS scoring systems as predictors of mortality in the medical intensive care unit. J Intens Care Med 1997;12:12.
109. Momotani N, Ito K, Hamada N, et al. Maternal hyperthyroidism and congenital malformation in the offspring. Clin Endocrinol 1984;20:695.
110. Davis LE, Lucas MJ, Hankins GDV, et al. Thyrotoxicosis complicating pregnancy. Am J Obstet Gynecol 1989;160:63.
111. Harjai KJ, Licata AA. Effects of amiodarone on thyroid function. Ann Intern Med 1997;126:63.
112. Lazarus JH. The effects of lithium therapy on thyroid and thyrotropin-releasing hormone. Thyroid 1998;8:909.
113. Shimizu M, Hirokawa M, Manabe T, et al. Lithium associated autoimmune thyroiditis. J Clin Pathol 1997;50(2):172-4.
114. Dayan CM. Interpretation of thyroid function tests [review]. Lancet 2001;357(9256):619-24.
115. Goichot B, Perrin AE. Thyrotropin as first-line thyroid test. Lancet 2001;358(9280):509.
116. Shagam JY. Thyroid disease: an overview. Radiol Technol 2001;73(1):25-40.
117. Wang CY, Chang TJ, Chang TC, et al. Thyroidectomy or radioiodine? The value of ultrasonography and cytology in assessment of nodular lesions in Graves' hyperthyroidism. Am Surg 2001;67(8):721-6.
118. Braga M, Cavalcanti TC, Collaco LM, et al. Efficacy of untrasound-guided fine-needle aspiration biopsy in the diagnosis of complex thyroid nodules. J Clin Endocrinol Metab 2001;86(9):4089-91.
119. Gross JL. Ultrasonography in management of nodular thyroid disease. Ann Intern Med 2001;135(5):383-4.
120. Hales MS, Hsu FS. Needle tract implantation of papillary carcinoma of the thyroid following aspiration biopsy. Acta Cytol 1990;34:801.